Last edition
News about "Covid 19 pneumonia."
Genentech, a member of the Roche Group, announced the US Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standard
Covid 19 Pneumonia. | 26/03/2020 | By Darshana | 499
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members